Research & Development
Inflammation: Page 4
Researchers link protein group to end-stage renal disease
Researchers found that a group of 17 circulating inflammatory proteins were consistently associated with a patient's progression to end-stage renal disease. They believe that the protein group, called the kidney risk inflammatory signature (KRIS), could alert physicians to the chance that a diabetic patient's disease is at risk of progressing.
April 22, 2019
Open-access software takes aim at ELISA test variability
Hospitals and clinical labs use ELISA tests to measure biomarkers in substances such as blood, plasma, and urine. ELISA test kits used for medical applications are tightly regulated to ensure accuracy and consistency. However, ELISA test kits used for research applications are unregulated, a situation that results in variability between different testing kits and clinical labs.
April 17, 2019
FDA gives nod to Hologic assay for STI bacterium
Called Aptima, it is the first test to be cleared by the FDA for M. genitalium, which is associated with inflammation of the urethra (nongonococcal urethritis) in men and inflammation of the cervix (cervicitis) and infection of the reproductive organs (pelvic inflammatory disease) in women.
January 28, 2019
Page 4 of 4